In partnership with AdvaMed, industry leaders from across the country will come to Washington DC with the mission of educating members of Congress on the value of life science innovation.
As medtech innovators, your voice is essential in humanizing the industry and aiding policy-makers in understanding the challenges facing life science organizations that are – or may in the future – threaten a company’s existence or negatively impact the industry’s ability to innovate and develop medical products, technologies, and treatments.
Join Oregon Bio for a unique advocacy experience. March 5th schedule starts at 1:30 PM with a welcome, series of briefings and an evening reception. March 6th includes a series of daylong meetings on Capitol Hill.
Key medtech legislative priorities include:
- R&D Expensing
- Artificial Intelligence
Space is limited. Inquire today.